Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|1|3|311-318

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.1, Iss.3, 2006-09, pp. : 311-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costimulation Blockade in the Treatment of Rheumatic Diseases

By Liossis S-N.C.  

BioDrugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 95-102

Adis International

Access to resources Recommend Favorite

Safety of Anti-TNF Alpha Agents in the Pregnant Psoriatic Patient

By  

Current Drug Therapy, Vol. 8, Iss. 1, 2013-03 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite

Pilot clinical trial of an anti-TNF monoclonal antibody for the treatment of septic shock

By BOILLOT A   CAPELLIER G   RACADOT E   WIJDENES J   HERVE P   BARALE F  

Clinical Intensive Care, Vol. 6, Iss. 2, 1995-04 ,pp. : 52-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Utility of Non-Conventional Applications of Anti-VEGF Treatment in Selected Retinal Diseases

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 117-122

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents

By  

Current Drug Therapy, Vol. 6, Iss. 1, 2011-02 ,pp. : 35-50

Bentham Science Publishers

Access to resources Recommend Favorite